Abstract:Author summary Reconstructing gene regulatory network (GRN) is an essential question in systems biology. The lack of temporal information in sample-based transcriptomic data leads to a major challenge for inferring GRN and its translation to precision medicine. To address the above challenge, we propose to decode the latent temporal information underlying cancer progression via ordering patient samples based on transcriptomic similarity, and design a latent-temporal progression-based Bayesian method to infer GRNs from sample-based transcriptomic data of cancer patients. The advantages of our method include its capability to infer causal GRNs (with directed and signed edges) and its robustness to the measurement variability in the data. Performance evaluation using both simulated data and real data demonstrate that our method outperforms other existing methods in both pseudotime inference and GRN inference. Our method is then applied to reconstruct EMT regulatory networks in bladder cancer and to identify key regulators underlying progression of breast cancer. Importantly, the predicted key regulators/interactions are experimentally validated. Our study suggests that inferring dynamic progression trajectory from static expression data of tumor samples helps to uncover regulatory mechanisms underlying cancer progression and to discovery key regulators which may be used as candidate drug targets. Unraveling molecular regulatory networks underlying disease progression is critically important for understanding disease mechanisms and identifying drug targets. The existing methods for inferring gene regulatory networks (GRNs) rely mainly on time-course gene expression data. However, most available omics data from cross-sectional studies of cancer patients often lack sufficient temporal information, leading to a key challenge for GRN inference. Through quantifying the latent progression using random walks-based manifold distance, we propose a latent-temporal progression-based Bayesian method, PROB, for inferring GRNs from the cross-sectional transcriptomic data of tumor samples. The robustness of PROB to the measurement variabilities in the data is mathematically proved and numerically verified. Performance evaluation on real data indicates that PROB outperforms other methods in both pseudotime inference and GRN inference. Applications to bladder cancer and breast cancer demonstrate that our method is effective to identify key regulators of cancer progression or drug targets. The identified ACSS1 is experimentally validated to promote epithelial-to-mesenchymal transition of bladder cancer cells, and the predicted FOXM1-targets interactions are verified and are predictive of relapse in breast cancer. Our study suggests new effective ways to clinical transcriptomic data modeling for characterizing cancer progression and facilitates the translation of regulatory network-based approaches into precision medicine.

LaGrACE: Estimating gene program dysregulation using latent gene regulatory network for biomedical discovery

Functional Inference of Gene Regulation Using Single-Cell Multi-Omics

Gene Set linkage analysis: a tool for interpreting the overall functional impacts of observed transcriptomic changes

SMGR: a joint statistical method for integrative analysis of single-cell multi-omics data

Inferring latent temporal progression and regulatory networks from cross-sectional transcriptomic data of cancer samples

Enhancing gene regulatory network inference through data integration with markov random fields

GRaNIE and GRaNPA: inference and evaluation of enhancer‐mediated gene regulatory networks

Inferring Gene Regulatory Relationships with A High-Dimensional Robust Approach

Using Graphical Adaptive Lasso Approach to Construct Transcription Factor and Microrna'S Combinatorial Regulatory Network in Breast Cancer

ACGLM: A Hybrid Approach to Select and Combine Gene Expression Regulation in Cancer Datasets

GRACE: Unveiling Gene Regulatory Networks with Causal Mechanistic Graph Neural Networks in Single-Cell RNA-Sequencing Data

A hybrid deep learning framework for gene regulatory network inference from single-cell transcriptomic data

scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks

DeepGRNCS: deep learning-based framework for jointly inferring gene regulatory networks across cell subpopulations

SLIVER: Unveiling large scale gene regulatory networks of single-cell transcriptomic data through causal structure learning and modules aggregation

Functional Cis -Regulatory Genomics for Systems Biology

Continuous lifelong learning for modeling of gene regulation from single cell multiome data by leveraging atlas-scale external data

Epiregulon: Inference of single-cell transcription factor activity to predict drug response and drivers of cell state

Globally learning gene regulatory networks based on hidden atomic regulators from transcriptomic big data

BGRMI: A method for inferring gene regulatory networks from time-course gene expression data and its application in breast cancer research

Nested epistasis enhancer networks for robust genome regulation